Bullseye Asset Management’s Health Catalyst HCAT Stock Holding History

Bullseye Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-47,031	Closed	-$549K	–	74
2023 Q1	$549K	Hold	47,031	–	–	0.28%	65
2022 Q4	$500K	Sell	47,031 -8,403	-15%	-$81.1K	0.27%	65
2022 Q3	$538K	Sell	55,434 -698	-1%	-$9.24K	0.31%	64
2022 Q2	$813K	Buy	56,132 +63	+0.1%	+$1.07K	0.46%	62
2022 Q1	$1.47M	Hold	56,069	–	–	0.67%	53
2021 Q4	$2.2M	Hold	56,069	–	–	0.87%	47
2021 Q3	$2.8M	Sell	56,069 -217	-0.4%	-$11.8K	0.97%	38
2021 Q2	$3.12M	Hold	56,286	–	–	1.05%	42
2021 Q1	$2.63M	Hold	56,286	–	–	0.98%	45
2020 Q4	$2.45M	Sell	56,286 -489	-0.9%	-$18K	0.91%	41
2020 Q3	$2.08M	Sell	56,775 -38	-0.1%	-$1.29K	0.95%	40
2020 Q2	$1.66M	Buy	56,813 +30,408	+115%	+$840K	0.88%	44
2020 Q1	$690K	Buy	26,405 +905	+4%	+$27.6K	0.82%	42
2019 Q4	$885K	Buy	+25,500	New	+$844K	0.86%	42

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bullseye Asset Management's HCAT Position: Q2 2023 in Review

Bullseye Asset Management sold out of Health Catalyst (HCAT) in Q2 2023, closing a stake of 47,031 shares — an estimated $549K sold.

Bullseye Asset Management first reported a position in HCAT in Q4 2019 and held it in 14 quarters. The position peaked at $3.12M in Q2 2021. 154 funds tracked by Wall St. Rank hold HCAT as of Q2 2023.

Bullseye Asset Management reported no remaining Health Catalyst position as of Q2 2023 after selling out during the quarter.
Bullseye Asset Management sold 47,031 Health Catalyst shares in Q2 2023, an estimated $549K.
Bullseye Asset Management first reported a position in Health Catalyst in Q4 2019 and held it in 14 quarters.
Bullseye Asset Management's Health Catalyst position peaked at $3.12M in Q2 2021.
154 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2023.

Based on Bullseye Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.